Page last updated: 2024-08-21

erythromycin and Disbacteriosis

erythromycin has been researched along with Disbacteriosis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Bennett, PR; Brown, RG; MacIntyre, DA1
Bennett, PR; Brown, RG; Holmes, E; Kindinger, LM; Lee, YS; Lehne, B; MacIntyre, DA; Marchesi, JR; Nicholson, JK; Smith, A; Terzidou, V1

Reviews

1 review(s) available for erythromycin and Disbacteriosis

ArticleYear
Vaginal Microbiome in Preterm Rupture of Membranes.
    Obstetrics and gynecology clinics of North America, 2020, Volume: 47, Issue:4

    Topics: Anti-Bacterial Agents; Chorioamnionitis; Dysbiosis; Erythromycin; Female; Fetal Membranes, Premature Rupture; Gestational Age; Humans; Infant, Newborn; Lactobacillus; Microbiota; Neonatal Sepsis; Pregnancy; Premature Birth; Risk Factors; Vagina

2020

Other Studies

1 other study(ies) available for erythromycin and Disbacteriosis

ArticleYear
Vaginal dysbiosis increases risk of preterm fetal membrane rupture, neonatal sepsis and is exacerbated by erythromycin.
    BMC medicine, 2018, 01-24, Volume: 16, Issue:1

    Topics: Adult; Antibiotic Prophylaxis; Cohort Studies; Disease Progression; Dysbiosis; Erythromycin; Female; Fetal Membranes, Premature Rupture; Humans; Infant, Newborn; Microbiota; Neonatal Sepsis; Pregnancy; Premature Birth; Prenatal Care; Risk Factors; RNA, Bacterial; RNA, Ribosomal, 16S; Vagina

2018